Conference item : Abstract

Ruxolitinib compared with best available therapy for essential thrombocythaemia patients resistant or intolerant to hydroxycarbamide in majic: an investigator lead randomized trial

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Harrison, C., Mead, A., Panchal, A., Fox, S., Yap, C., Houlton, A., Aliman, S., Wood, M., Chen, F., Coppell, J., Panoskaltsis, N., Scherber, R., Geyer, H., Dueck, A., Mesa, R., & McMullin, M. (2016). Ruxolitinib compared with best available therapy for essential thrombocythaemia patients resistant or intolerant to hydroxycarbamide in majic: an investigator lead randomized trial. Haematologica, 101(S1), 97.

MLA Style

Harrison, C., et al. “Ruxolitinib Compared with Best Available Therapy for Essential Thrombocythaemia Patients Resistant or Intolerant to Hydroxycarbamide in Majic: an Investigator Lead Randomized Trial.” Haematologica, vol. 101, no. S1, Ferrata Storti Foundation, 2016, p. 97.

Chicago Style

Harrison, C, A Mead, A Panchal, S Fox, C Yap, A Houlton, S Aliman, et al. 2016. “Ruxolitinib Compared with Best Available Therapy for Essential Thrombocythaemia Patients Resistant or Intolerant to Hydroxycarbamide in Majic: an Investigator Lead Randomized Trial.” In Haematologica, 101:97. Ferrata Storti Foundation.
Share
Print

Authors

+ Harrison, C More by this author

Role:: Author

+ Mead, A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Sub department:: RDM Clinical Laboratory Sciences
Role:: Author
ORCID:: 0000-0001-8522-1002

+ Panchal, A More by this author

Role:: Author

+ Fox, S More by this author

Role:: Author

+ Yap, C More by this author

Role:: Author

More authors...

Publisher:: Ferrata Storti Foundation
Host title:: Haematologica
Journal:: Haematologica More from this journal
Volume:: 101
Issue:: S1
Pages:: 97
Publication date:: 2016-06-30
Acceptance date:: 2016-05-30
EISSN:: 1592-8721
ISSN:: 0390-6078

Subtype:: Abstract
Pubs id:: pubs:719265
UUID:: uuid:726cc1df-0dfc-424f-8aa2-1638ee09f484
Local pid:: pubs:719265
Source identifiers:: 719265
Deposit date:: 2019-04-04

Terms of use

Copyright holder:: Ferrata Storti Foundation
Copyright date:: 2016
Notes:: © 2016 by Ferrata-Storti Foundation/European Hematology Association. All rights reserved.. This is a conference abstract presented at the 21st Congress of the European Hematology Association, 9-12 June 2016, Copenahgen, Denmark. The final version is available online from Ferrata Storti Foundation at: http://www.haematologica.org/content/101/s1/1

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP